Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
申请人:Pfizer Products Inc.
公开号:EP1006113A1
公开(公告)日:2000-06-07
The present invention relates to compounds of the formula
wherein R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of Formula I and to methods of inhibiting abnormal cell growth, including cancer, in a mammal by administering the compounds of Formula I to said mammal.
本发明涉及如下式的化合物
其中 R1、R2、R3 和 R4 如本文所定义。本发明还涉及含有式 I 化合物的药物组合物,以及通过向哺乳动物施用式 I 化合物来抑制哺乳动物体内异常细胞生长(包括癌症)的方法。